MedPath

Study of a Primary Care Hypoglycemia Prevention Program

Not Applicable
Active, not recruiting
Conditions
Diabetes Mellitus
Hypoglycemia
Interventions
Other: Clinic Staff Group
Other: Primary Care Physician Group
Other: Patient Group (Hypoglycemia Prevention Program)
Registration Number
NCT06353217
Lead Sponsor
Johns Hopkins University
Brief Summary

This is a single site, pre-post pilot study. The objective is to evaluate the acceptability and feasibility of a primary care hypoglycemia prevention program for patients taking hypoglycemia-causing medications. The study will also evaluate relevant process outcomes and clinical outcomes for refining the intervention and planning for a larger efficacy trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
35
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Clinic Staff InvolvementClinic Staff Group-
Primary Care Physician (PCP) InvolvementPrimary Care Physician GroupPCPs will be given access to the Hypoglycemia Prevention toolkit
Patient InvolvementPatient Group (Hypoglycemia Prevention Program)Patients who participate in the study will undergo one Baseline Clinic Visit (baseline usual care), and one Intervention clinic visit.
Primary Outcome Measures
NameTimeMethod
Overall acceptability to clinic staffImmediately after the intervention

Mean score for overall acceptability on clinic staff intervention evaluation survey (developed for this study, range 1-completely unacceptable, to 5-completely acceptable)

Overall acceptability to primary care providersImmediately after the intervention

Mean score for overall acceptability on primary care provider intervention evaluation survey (developed for this study, range 1-completely unacceptable, to 5-completely acceptable)

Overall acceptability to patientsImmediately after the intervention

Mean score for overall acceptability on patient intervention evaluation survey (developed for this study, range 1-completely unacceptable, to 5-completely acceptable)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Johns Hopkins University School of Medicine

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath